NCT03948724Completed
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
Randomized Controlled Trial Evaluating the Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
Source: ClinicalTrials.gov · Last updated 31 Aug 2026
Brief summary (registry, in English)
The aim of this therapeutic education program is to reduce the apparition of immune-related Adverse Event with patients treated with ICI
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 412 (actual)
- First submitted
- 10 May 2019
- Start date
- 11 Dec 2019
- Primary completion date
- 4 Aug 2023
- Lead sponsor
- Institut Cancerologie de l'Ouest
- Diseases
- Head and neck cancer, Kidney cancer, Melanoma, Lung cancer
- NCT number
- NCT03948724
What you commit to
- Study type: Interventional
- Participants enrolled: 412
- From 11 Dec 2019 to the primary completion date, 4 Aug 2023
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient receiving corticosteroid or immunosuppressant 14 days before inclusion
Other
- Immunocompromised patient
- Uncontrolled brain metastases
- Refusal to participate, patient protected by guardianship
- Patient unable to understand the study or unable to follow the education sessions
Who the study is looking for
- Patient with Melanoma, Non-Small Cell Bronchial Cancer, renal cell carcinoma, Ca carcinomas of the upper airways to be treated with ICI
- Patient who has never received treatment by ICI
- Informed patient who signed his consent
- Age \> or = 18 years
- Social insurance
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut de Cancerologie de L'Ouest Coordinator of this site? Confirm its status | Angers | France | Unknown status |
| CHU Angers Coordinator of this site? Confirm its status | Angers | France | Unknown status |
| Centre François Baclesse Coordinator of this site? Confirm its status | Caen | France | Unknown status |
| Centre D'Oncologie Et de Radiotherapie 37 Coordinator of this site? Confirm its status | Chambray-lès-Tours | France | Unknown status |
| CHD Vendée Coordinator of this site? Confirm its status | La Roche-sur-Yon | France | Unknown status |
| Centre Oscar Lambret Coordinator of this site? Confirm its status | Lille | France | Unknown status |
| Centre Leon Berard Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
| Institut Curie Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| Institut de Cancérologie de Lorraine Coordinator of this site? Confirm its status | Vandœuvre-lès-Nancy | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.